Biomedicines · 2020 · 43 citations · 26 references
MedicineMolecular BiologyOncologyMolecular DiagnosticsMolecular OncologyTranscriptomicsCancer BiomarkersCancer Molecular DiagnosticsCirculating Tumor Dna AnalysisExosome AnalysisMolecular Tumor ProfilingProstate CancerBlood-based BiomarkersCirculating Tumor ExosomesDigital PcrExosomesExtracellular VesiclesLiquid Biopsy DetectionLiquid Biopsy SensitivityTumor-derived Exosomes
We evaluated the advantages and the reliability of novel protocols for the enrichment of tumor extracellular vesicles (EVs), enabling a blood-based test for the noninvasive parallel profiling of multiple androgen receptor (AR) gene alterations. Three clinically relevant AR variants related to response/resistance to standard-of-care treatments (AR-V7 transcript, AR T878A point mutation and AR gene amplification) were evaluated by digital PCR in 15 samples from patients affected by Castration-Resistant Prostate Cancer (CRPC). Plasma was processed to obtain circulating RNA and DNA using protocols based on tumor EVs enrichment through immuno-affinity and peptide-affinity compared to generic extraction kits. Our results showed that immuno-affinity enrichment prior to RNA extraction clearly outperforms the generic isolation method in the detection of AR-V7, also allowing for a distinction between responder (R) and non-responder (NR) patients. The T878A mutation was detected, overall, in nine out of 15 samples and no approach alone was able to reveal mutations in all harboring samples, showing that the employed methods complement each other. AR amplification was detected in the majority of CRPC samples analysed using either cell-free DNA (cfDNA) or exosome isolation kits (80%). We demonstrated that selective isolation of a subset of circulating exosomes enriched for tumor origin, rather than analysis of total plasma exosomes, or total plasma nucleic acids, increases sensitivity and specificity for the detection of specific alterations.
26
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse, Jaeil Ahn, Rehan Akbani et al. · Cell · 2015 · 3.2K citations · Full text
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis, Changxue Lu, Hao Wang et al. · New England Journal of Medicine · 2014 · 2.7K citations · Full text
Medicine, Oncology, Pharmacology +17
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso, Yi-Mi Wu, Dan R. Robinson et al. · Nature · 2012 · 2.6K citations
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran, Davide Prandi, Juan Miguel Mosquera et al. · Nature Medicine · 2016 · 1.7K citations · Full text
Jos Veldscholte, C. Ris-Stalpers, George G. J. M. Kuiper et al. · Biochemical and Biophysical Research Communications · 1990 · 945 citations · Full text